Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 20/1/2018
SIETES contiene 92186 citas

 1 a 20 de 591 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Bjørk M, Riedel B, Spiqset O, Veiby G, Kolstad E, Daltveit AK, Gilhus NE. Association of folic acid supplementation during pregnancy with the risk of autistic traits in children exposed to antiepileptic drugs In utero. JAMA Neurology 2017:26 de diciembre. [Ref.ID 102193]
2. Cita con resumen
Bromley RL, Weston J, Marson AG. Maternal use of antiepileptic agents during pregnancy and major congenital malformations in children. JAMA 2017;318:1700-1. [Ref.ID 102140]
3. Cita con resumen
Chang S-H, Chou I-J, Yeh Y-H, Chiou M-J, Wen M-S, Kuo C-T, See L-C, Kuo C-F. Association between use of non-vitamin K oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation. JAMA 2017;318:1250-9. [Ref.ID 102073]
4. Cita con resumen
Zaccara G, Giovannelli F, Giorgi FS, Franco V, Gasparini S, Tacconi FM. Do antiepileptic drugs increase the risk of infectious diseases? A meta-analysis of placebo-controlled studies. Br J Clin Pharmacol 2017;83:1873-9. [Ref.ID 102027]
5. Cita con resumen
Anónimo. Brivaracétam et épilepsie partielle. Prescrire 2017;37:412-3. [Ref.ID 101999]
6. Cita con resumen
Anónimo. Excès de poils d'origine médicamenteuse. Prescrire 2017;37:26. [Ref.ID 101367]
7. Cita con resumen
Anónimo. Pérampanel et épilepsies généralisées réfractaires. Prescrire 2016;36:492-3. [Ref.ID 100550]
8. Cita con resumen
Hesdorffer CS, Longo DL. Drug-induced megaloblastic anemia. N Engl J Med 2015;373:1649-58. [Ref.ID 99629]
9.Enlace a cita original Cita con resumen
Martín-Merino E, de Abajo FJ, Gil M. Risk of toxic epidermal necrolysis and Stevens-Johnson syndrome associated with benzodiazepines: a population-based cohort study. Eur J Clin Pharmacol 2015;71:759-66. [Ref.ID 99180]
10. Cita con resumen
Velez-Ruiz NJ, Meador KJ. Neurodevelopmental effects of fetal antiepileptic drug exposure. Drug Saf 2015;38:271-8. [Ref.ID 98950]
11.Tiene citas relacionadas Cita con resumen
Hay D, Hill M, Littlewood T. Neutropenia in primary care. BMJ 2014;349:g5340. [Ref.ID 98347]
12. Cita con resumen
13. Cita con resumen
Chung W-H, Chang W-C, Lee Y-S, Wu Y-Y, Yang -CH, Ho H-C, Chen MJ, Lin JY, Hui C-Y, Ho J-C, Wu W-M, Chen T-J, Wu T, Wu Y-R, Hsih M-S, Tu P-H, Chang C-N, Hsu C-N, Wu T-L, Choon S-E, Hsu C-K, Chen D-Y, Liu C-S, Lin C-Y, Kaniwa N, Saito Y, Takahashi Y, Nakamura R, Azukizawa H, Shi Y, Wang T-H, Chuang S-S, Tsai S-F, Chang C-J, Chang YS, Hung S-I, for the Taiwan Severe Cutaneous Adverse Reaction Consortium and the Japan Pharmacogenomics Data Science Consortium. Genetic variants associated with phenytoin-related severe cutaneous adverse reactions. JAMA 2014;312:525-34. [Ref.ID 97851]
14. Cita con resumen
Anónimo. Perampanel (Fycompa) for epilepsy. Med Lett Drugs Ther 2014;56:9-10. [Ref.ID 97220]
15. Cita con resumen
Anónimo. Drug-induced liver injury. Australian Prescriber 2013;36:168-9. [Ref.ID 96320]
17. Cita con resumen
Anónimo. Neuropathies périphériques d'origine médicamenteuse. Prescrire 2013;33:269-75. [Ref.ID 95342]
19.Tiene citas relacionadas Cita con resumen
Walters D. Making medicines evergreen. Flynn Pharma's reply. BMJ 2013;346:25. [Ref.ID 94836]
20.Tiene citas relacionadas Cita con resumen
Seleccionar todas
 1 a 20 de 591 siguiente >>